NRC Stock Analysis: Buy, Sell, or Hold?
NRC - National Research Corporation Common Stock (Delaware)
$22.19
0.37 (1.70%)
▲
5d:
+4.72%
30d:
+6.53%
90d:
+16.54%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Jul 27, 2026
0d
Get Alerted When NRC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: NRC shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: NRC shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$40.89
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$25.39
12.6% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 20.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: NRC is currently trading at $22.19, which is considered extended relative to its 30-day fair value range of $19.84 to $21.99. The stock's valuation (Forward PE: 21.1) is in line with its historical norms (20.0). At these levels, the market is pricing in 1.8% annual earnings growth.
Technical Outlook: Technically, NRC is in a strong uptrend. Immediate support is located at $19.79, while resistance sits at $22.99.
Market Sentiment: NRC scores 8/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $26.00 (+17.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NRC is in a strong uptrend. Immediate support is located at $19.79, while resistance sits at $22.99.
Market Sentiment: NRC scores 8/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $26.00 (+17.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$19.84 -
$21.99
Company Quality Score
39/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
29.5%
All Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (8/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($26.00)
- BULLISH: Expecting earnings turnaround to 1.8% growth with 4.0% revenue growth
- WARNING: Composite score 39/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$19.84 -
$21.99
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$19.79
Resistance Level
$22.99
Current Trend
Strong Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
21.13
Wall Street Target
$26.00
(+17.2%)
Revenue Growth (YoY)
4.0%
Earnings Growth (YoY)
-44.0%
Profit Margin
4.2%
Valuation Premium vs History
+1.8% premium
PE vs Historical
21.1 vs 20.0
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+1.8%
(market-implied from PE analysis)
1-Year Target
$22.59
(+2%)
2-Year Target
$23.00
(+4%)
3-Year Target
$23.41
(+6%)
3-Yr Target (if PE normalizes)
(PE: 21→20)
PE COMPRESSION
$22.15
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.1, Growth: 218.2%)
$74.89
(+238%)
Base:
(SPY PE: 20.1, Growth: 218.2%)
$71.12
(+221%)
Bear:
(PE: 17.1, Growth: 218.2%)
$60.45
(+172%)
📈
Valuation based on Current Earnings
Forward PE: 17.21 | Forward EPS (Implied): $1.29
Bull Case
$26.79
(+21%)
Analyst growth 15.0%, PE expands to 18.1
Base Case
$22.19
(0%)
Market implied 0.0%, PE stable at 17.2
Bear Case
$16.98
(-24%)
Severe decline -15.0%, PE contracts to 15.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 23, 2026 3:39 PM ET
Data refreshes hourly during market hours. Next update: 4:39 PM
Data refreshes hourly during market hours. Next update: 4:39 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NRC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$32 | 50 HOLD |
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$254 | 33 SELL |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 51 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 37 SELL |
|
BTSG
BrightSpring Health Serv… |
STRONG BUY
12 analysts |
$79 | 63 BUY |
